Casirivimab + imdevimab
Indicated for: COVID-19
J06BD07 Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies
Letter C · page 3
Indicated for: COVID-19
J06BD07 Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies
Indicated for: invasive candidiasis; fungal infections
Indicated for: malignant ascites
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: bacterial infections
Indicated for: pain and inflammation
Indicated for: hypertension
Indicated for: prevention of typhoid fever
J07AP02 Antiinfectives for systemic use | Bacterial vaccines | Typhoid vaccines
Indicated for: cancer
Indicated for: epilepsy
N03AX25 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
Indicated for: bacterial infections